Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient - CME

CME

Title: Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Description: Psoriasis (PsO) is a chronic, systemic inflammatory disease that affects 3% of US adults; it has been increasingly prevalent over the past years. The disorder is often characterized by chronicity, high grade of disability, and related comorbidities. Notably, biologic agents targeting the interleukin (IL)-23/IL-17 axis have demonstrated improved efficacy compared with conventional therapies and include several FDA-approved agents. This case-based continuing education program is intended to increase clinician knowledge of the key therapeutic targets within the IL-23/IL-17 pathway and the role of biologic agents directed against these key targets in managing PsO, including in difficult-to-treat areas. The mechanisms of action, efficacy, safety, and limitations of these agents are discussed, as well as methods to identify patients who would optimally benefit from these targeted biologic therapies.

Target Audience: This educational activity is directed toward dermatology nurse practitioners, physician assistants, and other health care providers involved in managing PsO.

Learning Objectives

Apply recommended eligibility criteria to determine patients appropriate for anti–IL-17 and anti–IL-23 biologic therapies based on disease severity of PsO
Evaluate safety and efficacy data for approved anti–IL-17 and anti–IL-23 biologic agents directed against key treatment targets within the IL-23/IL-17 inflammatory pathway for managing PsO
Develop holistic, individualized management plans for patients with PsO that incorporate anti–IL-17 or anti–IL-23 biologic therapy based on patient-specific needs and shared goals of therapy

Disclosures and Disclaimers: Disclosures: All relevant financial relationships for anyone with the ability to control the content of this educational activity have been mitigated. Disclaimer: Content is current as of the date this activity was released. The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

Accredited Providers

Commercial Support

Credit Information

Credit Type	Units / Unit Type	Board
AAPA Category 1 Credit	1 Credits	ACCME- Accreditation Council for Continuing Medical Education